Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
FibroGen announced interim results from an ongoing Phase 2 study evaluating FG-3019 for the treatment of idiopathic pulmonary fibrosis (IPF).
CSL Behring has announced the availability of DNA1 Advanced Alpha-1 Screening (DNA1), a test designed to improve the diagnosis of Alpha-1 Antitrypsin Deficiency (Alpha-1).
Pfizer Consumer Healthcare has launched Robitussin Maximum Strength Cough + Chest Congestion DM and Robitussin Maximum Strength Nighttime Cough DM syrup.
The amount of corticosteroids delivered by nebulizers in children with asthma differs from the prescribed dose, the amount varying with drug formulation.
This activity will explain different ways to treat patients suffering from COPD using medications and how to determine ...1.00 CE for Nurses
The goal of this program is to improve the management of office emergencies.2.00 AMA PRA Category 1 Credit(s)TM
The goal of this program is to improve the management of the difficult airway.2.00 AMA PRA Category 1 Credit(s)TM